179 related articles for article (PubMed ID: 35948927)
1. Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting.
Balitzer D; Tsai JH; Gill RM
Diagn Pathol; 2022 Aug; 17(1):65. PubMed ID: 35948927
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
[TBL] [Abstract][Full Text] [Related]
3. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
[TBL] [Abstract][Full Text] [Related]
4. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
[TBL] [Abstract][Full Text] [Related]
5. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease and liver transplantation.
Khan RS; Newsome PN
Metabolism; 2016 Aug; 65(8):1208-23. PubMed ID: 26997540
[TBL] [Abstract][Full Text] [Related]
7. Evidence of bias during liver transplant evaluation of non-alcoholic steatohepatitis cirrhosis patients.
Danford CJ; Iriana S; Shen C; Curry MP; Lai M
Liver Int; 2019 Jun; 39(6):1165-1173. PubMed ID: 30809932
[TBL] [Abstract][Full Text] [Related]
8. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy.
Nasser-Ghodsi N; Mara K; Allen AM; Watt KD
Clin Transplant; 2022 Aug; 36(8):e14714. PubMed ID: 35594161
[TBL] [Abstract][Full Text] [Related]
9. Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients.
Losurdo G; Castellaneta A; Rendina M; Carparelli S; Leandro G; Di Leo A
Aliment Pharmacol Ther; 2018 Mar; 47(6):704-714. PubMed ID: 29359341
[TBL] [Abstract][Full Text] [Related]
10. Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation.
Germani G; Laryea M; Rubbia-Brandt L; Egawa H; Burra P; OʼGrady J; Watt KD
Transplantation; 2019 Jan; 103(1):57-67. PubMed ID: 30335694
[TBL] [Abstract][Full Text] [Related]
11. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
[TBL] [Abstract][Full Text] [Related]
12. Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation.
Garcia RF; Morales E; Garcia CE; Saksena S; Hübscher SG; Elias E
Arq Gastroenterol; 2001; 38(4):247-53. PubMed ID: 12068535
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
17. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.
Hernandez-Alejandro R; Croome KP; Drage M; Sela N; Parfitt J; Chandok N; Marotta P; Dale C; Wall W; Quan D
World J Gastroenterol; 2012 Aug; 18(31):4145-9. PubMed ID: 22919246
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
Piazza NA; Singal AK
Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
[TBL] [Abstract][Full Text] [Related]
19. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
[TBL] [Abstract][Full Text] [Related]
20. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.
Kappus M; Abdelmalek M
Clin Liver Dis; 2017 May; 21(2):321-335. PubMed ID: 28364816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
